Combination of Janus kinase inhibitor and biologic for recalcitrant severe atopic dermatitis.

The article explores the combination of Janus kinase inhibitors and biologics for severe atopic dermatitis that is difficult to treat. The study collected data from patients who received this combination therapy and found positive outcomes in terms of improved skin condition and reduced itching. The study suggests that combining these treatments may be effective for patients with refractory atopic dermatitis, although further research is needed to fully understand the benefits and risks of this approach. [Extracted from the article]